ABSTRACT In mammals, fibroblast growth factor 23 (FGF23) regulates phosphate homeostasis in kidney by binding α-Klotho, a coreceptor of FGF23. FGF23 mRNA is highly expressed in bone and slightly expressed in liver, and is regulated by dietary phosphorus. Little is known about distribution and regulation of FGF23 mRNA in avian lineage. The expression of FGF23 and its coreceptor α-Klotho in chicken and embryo were investigated by real-time quantitative PCR. The effect of dietary phosphorus on FGF23 expression was measured. 36 laying hens at 25 wk were randomly assigned to three dietary available phosphorus (AP) treatments for 11 days: 0.15% AP (LP), 0.40% AP (MP), and 0.80% AP (HP). We first cloned the full coding sequence of FGF23 by the reverse transcription PCR from chicken liver and calvaria. Bioinformatics analysis indicated that the deduced amino acid sequence was 57-87% identical to FGF23 of other species. In adult chicken FGF23 mRNA was expressed at unexpected higher level in liver than other tissues evaluated, including calvaria, femur, tibia, medullary bone, brain, spleen, duodenum, jejunum, ileum, heart and kidney (P < 0.0001), and α-Klotho was expressed at highest level in kidney. However, in 18-d chicken embryos, FGF23 mRNA level was much higher in tibia than in liver, heart and jejunum (P < 0.0001). Chickens at 2, 25, 50 and 80 wk had higher FGF23 expression in liver than 18-d chicken embryos, whereas chickens at 25 wk had lower FGF23 expression in tibia than 18-d chicken embryos and 2-wk-old chickens. HP diets significantly increased serum inorganic phosphorus level (P < 0.001) and FGF23 expression (P < 0.05) in bone tissue compared with LP diets, however, FGF23 mRNA abundance in liver was not changed significantly (P > 0.05) by dietary phosphorus treatments. In conclusion, FGF23 mRNA expression pattern in chicken was clearly different from that in mammals and dietary phosphorus regulated the expression of FGF23 in a tissue-specific way.
organic phosphorus by improving the utilization of phytate (Faridi et al., 2015; Humer et al., 2015) . Current knowledge of the regulation of phosphorus metabolism is based on the network of parathyroid hormone and 1,25-dihydroxyvitamin D 3 (Dudas et al., 2002; Marks et al., 2010; Bouillon and Suda, 2014) .
As a known regulator of phosphate homeostasis, fibroblast growth factor 23 (FGF23) increases renal phosphate excretion (Berndt and Kumar, 2007) and reduces the amount of phosphate absorption from the gut (Shimada et al., 2004) in mammals. Circulating FGF23 may regulate phosphate homeostasis in chicken. Chicks with circulating anti-FGF-23 antibody has similar plasma phosphate and bone ash with chicks fed with the phosphate replete diet, when fed with a phosphorus deficient diet, suggesting the increased phosphate utilization in chicks (Bobeck et al., 2012) . Neutralization of FGF-23 reduces excreta phosphorus of laying hens and chicks (Ren et al., 2017a, b) . In mammals, the effects of FGF23 on phosphate homeostasis are mediated by binding α-Klotho, a coreceptor of FGF23 (Urakawa et al., 2006) , which deficiency results in osteoporosis, osteomalacia, vascular calcification and peripheral insulin sensitivity (Kuro-o et al., 1997) .
In mammals, it has been confirmed that FGF23 mRNA is primarily produced by bone (Liu et al., 2003; Mirams et al., 2004; Yoshiko et al., 2007; Bonewald and Wacker, 2013) and is regulated by dietary phosphorus (Ito et al., 2005; Perwad et al., 2005) . However, FGF23 mRNA expression profile and regulation by phosphorus in avian species have not yet been reported.
In the present study, for the first time in avian species, we investigated chicken FGF23 mRNA expression profile and evaluated the effect of dietary phosphorus on FGF23 mRNA expression in liver and bone. The results of this study will provide a foundation for understanding the functions of the chicken FGF23 gene.
MATERIALS AND METHODS
All procedures in the study were approved by the Animal Care Committee of Shandong Agricultural University and were performed in accordance with the guidelines for experimental animals of the Ministry of Science and Technology (Beijing, China).
Animal Experiment
Assessment of FGF23 mRNA in Tissues of Mice and Chickens Eight Hy-Line Brown female chickens of 80 wk of age were obtained from a local commercial farm. After sacrifice, the center part of calvaria, the proximal shaft of femur, the proximal shaft of tibia, medullary bone of femur, brain, spleen, duodenum, jejunum, ileum, heart and the right kidney were sampled for the analysis of FGF23 and α-Klotho mRNA expression profiles in chicken. Eight 18-d embryos of Hy-Line Brown were obtained from a local hatchery. The shaft of tibia, liver, heart and jejunum were obtained for the measurement of embryo FGF23 mRNA expression profile. Eight 18-d embryos were obtained and eight chickens were respectively obtained at 2-, 25-, 50-, and 80-wk of age. The liver and proximal shaft tibia were sampled for the measurement of the developmental changes of FGF23 mRNA. Eight female 12-wk-old KM mice were obtained from China Biologic Products, Inc. (Taian, China) for analysis of FGF23 expression in mouse liver and femur. All the tissue samples were snap frozen in liquid nitrogen and stored at −80
• C for subsequent RNA extraction.
Effect of Dietary Phosphorus on FGF23 Expression To determine the effect of dietary phosphorus intake on the FGF23 mRNA expression, 36 Hy-Line Brown laying hens at 25 wk of age with similar egg production and body weight were randomly divided into three groups of 12 hens and fed with the corn-soybean meal basal diets (Table 1 ) differed in available phosphorus (AP): 0.15% AP (LP), 0.40% AP (MP, con- trol), and 0.80% AP (HP). The experimental hens were reared in battery cage (0.40 m long × 0.45 m high × 0.40 m wide), with of 1 hen per cage. The light regime was 16 h light and 8 h dark. The hens had free access to feed and water. During the 11-d experimental period, feed intake, egg number, and egg weight were recorded every other day. At the end of the experiment, blood samples were collected from the wing vein of eight hens selected randomly from each group, and serum was separated by centrifugation at 1500 g for 15 min and stored at −20
• C until analysis. These hens were sacrificed by exsanguination (Close et al., 1997) . Liver, the proximal shaft of femur and tibia, and the center part of calvaria were immediately removed, snap-frozen in liquid nitrogen, and stored at −80
• C for further analysis.
RNA Extraction and cDNA Synthesis
Total RNA was extracted with the TRIzol Reagent (Invitrogen, San Diego, CA, USA) according to RNA isolation procedure from non-bone tissues. During RNA precipitation procedure of bone tissue, 0.25 mL isopropanol and 0.25 mL mix of 0.8 mol/L sodium citrate and 1.2 mol/L NaCl per 1 mL TRIzol Reagent were added to the aqueous phase for precipitating the RNA and maintaining proteoglycans of bone tissue in a soluble form. RNA quality was determined with agarose gel electrophoresis and a biophotometer (Eppendorf, Hamburg, Germany) detecting the UV absorbance ratio at 260 nm and 280 nm. The cDNA was synthesized using reverse transcription-polymerase chain reaction kit (Roche, Germany). The reaction was performed in a volume of 20 μL containing 1000 ng total RNA, 60 μmol/L random hexamer primer, 8 mmol/L MgCl 2 , 20 U RNase inhibitor, 1 mmol/L dNTP, 10 U reverse transcriptase, and PCR-grade water.
Cloning of Chicken FGF23 cDNA
According to the predicted FGF23 mRNA sequence in Gallus (GenBank accession number: XM 425,663), the following primers were generated to amplify the complete coding sequence (CDS) of FGF23 cDNA from the liver and calvaria of chicken at 25 wk of age by PCR: forward primer 5 -CTGCTCTTCATAAGCCCCTG-3 , reverse primer 5 -AGCCACCTTGAGGGTTAGAAA-3 . PCR program initially started with 94
• C for 5 min, following by 35 cycles of 30 s at 94
• C, 30 s at 55
• C, 1 min at 72
• C, and an extension step of 10 min at 72
• C. The purified PCR products were cloned into the PEASY-T1 vector (TransGen Biotech Co., Ltd., Beijing, China) and sequenced commercially (Sangon, Shanghai, China).
Sequence Analysis
DNAMAN software (Lynnon Biosoft, Quebec, Canada) was used for deducing the amino acid sequence and multiple sequence alignment. Signal peptides were predicted by SignalP 4.0 Server (http://www.cbs.dtu.dk/services/SignalP/). Sequence similarity analysis was performed by using the BLAST program (https://blast.ncbi.nlm.nih.gov/Blast.cgi).
Real-time Quantitative PCR (RT-qPCR) Assay for mRNA Expression
RT-qPCR analysis was conducted using 20 μL mix consisting of 2 μL the cDNA template (diluted 10 times), 0.25 μmol/L of each primer and 7 μL SYBR Green Master (Roche, Germany) through quantstudio 5 Real-Time PCR Systems (Applied Biosystems by Thermo Fisher Scientific). The cycling condition consisted of a predenaturation at 95
• C for 10 min followed by 40 cycles denaturation at 95
• C for 15 s and annealing and extension at 60
• C for 1 min. Standard curve and melt curve were plotted to calculate the efficiency of the primers. RT-qPCR production was sequenced (Sangon Biotech, Shanghai, China) to verify amplification specificity further. The sequences of primers were described in Table 2 . The relative expression quantity was calculated using the method of 2 −ΔΔCt (Livak and Schmittgen, 2001 ) and data were presented as fold changes relative to the reference sample. The three genes, β-actin, TATA-binding protein gene (TBP) and glyceraldehyde-3-phosphate dehydrogenase gene (GAPDH), were measured and the gene whose expression was not affected by experimental treatment was used as internal control gene.
Serum Parameters
Serum inorganic phosphorus (Pi) and ion calcium levels were determined using Pi assay kit by UV method and calcium assay kit by Arsenazo III method (Sichuan Maccura Biotechnology Co., Sichuan, China) respectively.
Statistical Analysis
Data were presented as the means ± SEM. For the variables FGF23 gene expression in tissues, a one-way ANOVA model was used to estimate the difference between tissues with individual chicken or embryo or mouse served as replicate (n = 8). For the variables FGF23 gene expression in liver, the proximal shaft of femur and tibia, a one-way ANOVA model was used to estimate the main effect of dietary AP level with individual experimental hen served as replicate (n = 8). The homogeneity of variances among groups was confirmed using Bartlett's test (SAS Institute). All the data were analyzed with SAS software (SAS version 8.1; SAS Institute Inc., Cary, NC, USA). When the main effect of the treatment was significant, the differences between means were assessed by Tukey's multiple comparisons test. P < 0.05 was considered statistically significant.
RESULTS

Cloning and Sequence Analysis of Chicken FGF23 Gene
Gallus gallus FGF23 was predicted to encode a protein of 254 amino acids, including three exons. In Hy-Line Brown laying hen, the complete CDS of FGF23 (GenBank accession number: KY498532) with 753 bp from liver (Figure 1 ) was 100% identical to that from calvaria ( Figure S1 ). There were two different bases between the CDS of Hy-Line Brown laying hen FGF23 and that of Gallus FGF23 by sequence alignment (Figure 1 ), but the deduced amino acid sequence of Hy-Line Brown laying hen FGF23 was 100% identical to that of Gallus ( Figure S2 ) and shared 57%, 58%, and 87% identity with that of human, mouse, and pigeon, respectively. Analysis using SignalP Server predicted that chicken FGF23 had a signal peptide containing 25 amino acids, which also existed in FGF23 of other species (Figure 2) . Chicken FGF23 included a conserved "RXXR" protease cleavage site similar to that of human, mouse, and pigeon (Figure 2 ).
FGF23 and α-Klotho Expression Profile
FGF23 mRNA expression was detected by RT-qPCR in all the evaluated tissues of chicken, and the level was significantly higher in liver than in other tissues including calvaria, femur, tibia, medullary bone, brain, spleen, duodenum, jejunum, ileum, heart and kidney ( Figure 3A , P < 0.0001). FGF23 mRNA expression levels in calvaria, femur and tibia were higher than in jejunum, ileum, kidney and heart ( Figure 3A , P < 0.01). FGF23 requires α-Klotho as cofactor to cognate FGF receptors to regulate phosphate homeostasis. The mRNA expression of α-Klotho was the highest in kidney in all the evaluated tissues ( Figure 3B , P < 0.0001). α-Klotho expressed at a relative medium level in calvaria, brain, and heart, which was significantly higher than that in liver, ileum, duodenum, medullary bone, tibia, and spleen ( Figure 3B , P < 0.01). In mice, FGF23 mRNA level in femur was far higher (>100 times) than in liver (Figure 4 , P < 0.0001).
The developmental changes of FGF23 mRNA expression were also analyzed. In embryos, the FGF23 mRNA expression was much higher in tibia than in liver, heart, and jejunum (P < 0.01, Figure 5A ). However, in liver, the FGF23 expression levels in 2-, 25-, 50-, 80-wk-old chickens were much higher (> 24 times) than in embryos (P<0.0001, Figure 5B ), and there was no difference among chickens at 2, 25, 50 and 80 wk (P > 0.05). The expression levels in tibia of embryos and 2-, 50-, 80-wk-old chickens were similar (P > 0.05), and the level in 25-wk-old chickens was lower than in embryos and 2-wk-old chickens (P < 0.05, Figure 5C ) and had no difference to 50-, 80-wk-old chickens (P > 0.05).
Effect of Dietary Phosphorus Supplementation on the Expression of FGF23 and α-Klotho mRNA
To detect the effect of phosphorus supplementation on the expression of FGF23 mRNA, laying hens were treated with 3 levels of dietary phosphorus. Serum Pi concentration was increased by dietary phosphorus supplementation in a dose dependent manner (P < 0.001, Table 3), but serum calcium level was not changed significantly (P > 0.05, Table 3 ). HP diets significantly up-regulated the level of FGF23 mRNA in calvaria, femur, and tibia compared with LP diets (P < 0.05, Figure 6 ), whereas the level in liver didn't differ significantly among the three groups (P > 0.05, Figure 6 ). HP diets up-regulated FGF23 mRNA expression significantly compared with MP diets only in calvaria (P < 0.05, Figure 6 ). However, the mRNA level of α-Klotho in kidney was not changed significantly by dietary phosphorus supplementation (P > 0.05, Figure 7 ). 
DISCUSSION
To date, most of studies on FGF23 have been carried out on mammalian species, such as human, rat, and mouse. Several recent reports have shown that anti-FGF-23 antibody treatment increased phosphorus retention in chickens (Bobeck et al., 2012; Ren et al., 2017a, b) . However, the information about FGF23 mRNA expression in avian species is limited. In this study, we first cloned cDNA sequence of chicken FGF23 predicted to encode a protein with a signal peptide and a RXXR motif, which was consistent with Figure 6 . Effect of the levels of dietary available phosphorus on the expression of FGF23 mRNA in the liver, calvaria, femur and tibia of laying hens treated with LP, MP and HP diets. Relative quantification of FGF23 expression was determined using real-time PCR. The internal control was TATA-binding protein (TBP) gene. Results were presented as fold changes relative to LP diets. Vertical bars represent the means ± SEM (n = 8). Bars with different letters are significantly different (P < 0.05). the observations from human and mammalian cell line (White et al., 2001; Liu et al., 2003) .
We first found that FGF23 mRNA was widely expressed in chicken tissues ( Figure 3A ), but the expression pattern was different to that of mammals. Human FGF23 mRNA expression was found to be higher in normal bone than in kidney, liver, thyroid, or parathyroid tissue (Mirams et al., 2004) . In rat, FGF23 mRNA levels were much higher (>30 times) in calvaria, femur, and incisor than in other tissues such as spleen, thymus, small intestine, liver, kidney, heart, and brain (Yoshiko et al., 2007) .The mouse FGF23 mRNA was expressed in bone, thymus, brain, heart, skeletal muscle, spleen, skin, lung, and testes, and the aboundance in bone was the highest (Liu et al., 2003; Mirams et al., 2004) . In line with the previous study, our results also indicated that mouse FGF23 mRNA level was much higher (>100 times) in femur than in liver (Figure 4) . These studies indicated that in mouse, rat, and human, FGF23 mRNA was predominantly expressed in bone and slightly expressed in liver. In contrast to the above findings in mammals, the present result indicated that FGF23 mRNA was expressed at unexpected higher level in liver than other tissues like bone in chickens ( Figure 3A) . In adult zebrafish, FGF23 is expressed in the corpuscles of Stannius, which are endocrine glands that lie in close proximity to the nephron (Mangos et al., 2012) . These results suggest that FGF23 expresses in a species-specific way. Chicken FGF23 was predicted to be a secreted protein with a signal peptide (Figure 2) , and its coreceptor, α-Klotho, was highly expressed in chicken kidney ( Figure 3B ), This result was in accordance with that in mammals whose α-Klotho mRNA is highly expressed in kidney (Kuro-o et al., 1997; Lim et al., 2015) . The result suggests that kidney may be an important target organ of FGF23 in chicken. This speculation was supported by the fact that kidney is a target organ of FGF23 in human, rat, and mouse Segawa et al., 2003; Shimada et al., 2004; Berndt and Kumar, 2007) .
In human embryo, FGF23 mRNA is only expressed in the heart and liver at 30-day and 8 wk gestation stage and not expressed at later developmental stages (Cormier et al., 2005) . Moreover, FGF23 is not required to regulate fetal phosphorus metabolism but exerts effects within 12 h after birth (Ma et al., 2017) . The rat FGF23 mRNA is detectable in multiple fetal and adult tissues and is highly expressed in adult calvaria, femur, and incisor, suggesting that FGF23 may be of less general importance in fetal than after birth (Yoshiko et al., 2007) . In contrast to the result in mammals, in chicken, FGF23 mRNA level was significantly higher in embryo tibia than other embryo tissues tested ( Figure 5A ), and had comparable expression level with chickens at different ages ( Figure 5C ), suggesting that FGF23 may play an important role in embryo bone development as well as after hatching. In contrast, FGF23 mRNA level was significantly lower in liver of embryo than in 2-, 25-, 50-, 80-wk-old chicken livers ( Figure 5B ). The result may imply that FGF23 functions differently in chicken embryo and in post-hatching chickens. To the best of our knowledge, this is the first report about the FGF23 expression in chicken, and the biological significance of the high expression of FGF23 in chicken liver needs to be investigated further. As the expression of FGF23 in embryos from 18-day to hatching was measured, the possibility that FGF23 has not yet been "up-regulated" for hatch needs to be investigated further.
Previous studies have shown that Pi regulates FGF23 mRNA expression in vitro and vivo. In mouse, the low (0.02%) Pi diets downregulated FGF23 mRNA expression in calvaria and levels of serum Pi compared with high (1%) Pi diets (Perwad et al., 2005) . In primary cultured rat osteoblasts and SV40-transformed human fetal bone cells, the mRNA expression of FGF23 was increased by high concentrations of extracellular phosphate (Mirams et al., 2004; Yamamoto et al., 2010) . In laying hen, the inhibition of FGF-23 action by neutralizing antibody reduced phosphorus excretion (Ren et al., 2017a, b) . According to these findings, we hypothesized that dietary phosphorus level may regulate the expression of FGF23 to maintain phosphate homeostasis in chicken. Compared with LP diets, HP diets upregulated serum Pi concentration (Table 3) and FGF23 mRNA level in bone tissue (Figure 6 ), indicating that bone FGF23 expression is regulated by dietary phosphorus level in chickens. In this study, feed intake (LP: 114.4±3.0 g, MP: 112.5±3.6 g, and HP: 112.4±5.0 g, P > 0.05) and egg production (LP: 57.8±1.7 g, MP: 56.1±0.9 g, and HP: 56.8±2.3 g/hen/day, P > 0.05) were not influenced by phosphorus supplementation, indicating that the laying performance was not influenced by dietary phosphorus level within a short period. The result indicates that the laying performance play a less important role in FGF23 expression in bone. Moreover, dietary phosphorus level didn't affect FGF23 mRNA level in liver (Figure 6 ), suggesting that FGF23 in chicken liver may not be involved in maintaining phosphate homeostasis and the function of hepatic FGF23 needs further study. However, there are some reports showing that calcium regulates FGF23 expression (Shimada et al., 2005; David et al., 2013) . Dietary calcium supplementation significantly increased FGF23 mRNA abundance in the femur of both wild-type and VDR KO mice (Shimada et al., 2005; David et al., 2013) , and the addition of calcium to the culture media also stimulated FGF23 message expression in MC3T3-E1 osteoblasts (David et al., 2013) . In this study, serum calcium concentration was not changed by dietary phosphorus supplementation (Table 3 ), suggesting that calcium is not involved in the altered FGF23 mRNA expression by dietary phosphorus level in the present study.
In mammals, FGF23 reduces expression of the Na-dependent phosphate transporters (type IIa and IIc) within the renal proximal tubular membranes to excrete excess phosphate (Berndt and Kumar, 2007) . In the present study, the α-Klotho mRNA in kidney was not influenced by dietary phosphorus treatment (Figure 7 ), indicating that dietary phosphorus level regulates the transcription of FGF23 but not its coreceptor α-Klotho.
In conclusion, FGF23 was widely expressed in chicken tissues. Interestingly, FGF23 mRNA expression pattern in chicken was clearly different from that in mammals; chicken had the highest FGF23 expression in liver rather than in bone like mammals. In chicken embryo, however, FGF23 was highly expressed in tibia. High dietary phosphorus level up-regulated FGF23 mRNA expression in bone, whereas had no influence on its expression in liver. The expression of α-Klotho was high in kidney in chickens. The result provides a basis for future investigations into the functions of FGF23 in chicken.
SUPPLEMENTARY DATA
Supplementary data are available at Poultry Science online. Figure S1 . Alignment coding sequence of liver FGF23 with that of calvaria FGF23. The black shading indicates identical sequences. Figure S2 . Alignment of Gallus FGF23 (XP 425, 663.1) with the deduced amino acid sequence of Hy-Line Brown laying hen FGF23. The black shading indicates identical amino acids.
